Tim Brend

668 total citations
17 papers, 445 citations indexed

About

Tim Brend is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Tim Brend has authored 17 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Tim Brend's work include Developmental Biology and Gene Regulation (6 papers), Glioma Diagnosis and Treatment (4 papers) and Genomics and Chromatin Dynamics (4 papers). Tim Brend is often cited by papers focused on Developmental Biology and Gene Regulation (6 papers), Glioma Diagnosis and Treatment (4 papers) and Genomics and Chromatin Dynamics (4 papers). Tim Brend collaborates with scholars based in United Kingdom, United States and France. Tim Brend's co-authors include Scott A. Holley, Dennis Summerbell, Peter Rigby, Jonathan D. Gilthorpe, Susan Short, Lucy F. Stead, Karan Patel, Thomas A. Ward, Anjana Patel and Heiko Wurdak and has published in prestigious journals such as Development, Cancer Research and Scientific Reports.

In The Last Decade

Tim Brend

17 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Tim Brend United Kingdom 9 360 69 63 59 58 17 445
Natalya Katanayeva Switzerland 10 432 1.2× 64 0.9× 90 1.4× 60 1.0× 52 0.9× 12 538
Linya You China 15 491 1.4× 77 1.1× 132 2.1× 53 0.9× 64 1.1× 26 606
Lan-Hsin Wang Taiwan 9 323 0.9× 59 0.9× 78 1.2× 35 0.6× 29 0.5× 12 416
Evgenya Y. Popova United States 14 473 1.3× 55 0.8× 83 1.3× 101 1.7× 37 0.6× 24 578
P. Taylur United States 10 415 1.2× 114 1.7× 93 1.5× 35 0.6× 67 1.2× 14 586
Sandra Gómez‐López United Kingdom 6 514 1.4× 54 0.8× 32 0.5× 48 0.8× 58 1.0× 7 601
Oliver Thompson United Kingdom 9 344 1.0× 116 1.7× 33 0.5× 51 0.9× 24 0.4× 9 462
Abel L. Carcagno Argentina 10 288 0.8× 80 1.2× 33 0.5× 65 1.1× 144 2.5× 11 447
Øystein Røsok Norway 10 287 0.8× 50 0.7× 57 0.9× 75 1.3× 57 1.0× 14 381
Helen J. Newbery United Kingdom 11 467 1.3× 36 0.5× 84 1.3× 61 1.0× 49 0.8× 13 562

Countries citing papers authored by Tim Brend

Since Specialization
Citations

This map shows the geographic impact of Tim Brend's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim Brend with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim Brend more than expected).

Fields of papers citing papers by Tim Brend

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim Brend. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim Brend. The network helps show where Tim Brend may publish in the future.

Co-authorship network of co-authors of Tim Brend

This figure shows the co-authorship network connecting the top 25 collaborators of Tim Brend. A scholar is included among the top collaborators of Tim Brend based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim Brend. Tim Brend is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Rogers, William, Guy R. Simpson, Carla S. Möller‐Levet, et al.. (2022). HOX and PBX gene dysregulation as a therapeutic target in glioblastoma multiforme. BMC Cancer. 22(1). 400–400. 12 indexed citations
3.
Brüning‐Richardson, Anke, Tim Brend, Hitesh J. Sanganee, et al.. (2021). GSK-3 Inhibition Is Cytotoxic in Glioma Stem Cells through Centrosome Destabilization and Enhances the Effect of Radiotherapy in Orthotopic Models. Cancers. 13(23). 5939–5939. 4 indexed citations
4.
5.
Brend, Tim, Alexander Wright, Thomas A. Ward, et al.. (2017). RAD51 Is a Selective DNA Repair Target to Radiosensitize Glioma Stem Cells. Stem Cell Reports. 8(1). 125–139. 106 indexed citations
6.
Guillotin, Delphine, Philip Austin, Marta O. Freitas, et al.. (2016). Drug-Repositioning Screens Identify Triamterene as a Selective Drug for the Treatment of DNA Mismatch Repair Deficient Cells. Clinical Cancer Research. 23(11). 2880–2890. 16 indexed citations
7.
Struve, Nina, Tim Brend, Leonie Ott, et al.. (2016). P06.20 EGFRvIII: a predictive marker for Temozolomide response in O6-methylguanine-DNA methyltransferase negative glioblastoma cells and tumor xenografts. Neuro-Oncology. 18(suppl_4). iv33–iv33. 1 indexed citations
9.
Brend, Tim, et al.. (2015). Abstract 3303: Radioresistance in glioma stem cells driven by Rad51 dependent homologous recombination repair. Cancer Research. 75(15_Supplement). 3303–3303. 1 indexed citations
10.
Tanaka, Tomoyuki, Tim Brend, Juan C. Cigudosa, et al.. (2014). Sequential Gene Targeting to Make Chimeric Tumor Models with De Novo Chromosomal Abnormalities. Cancer Research. 74(5). 1588–1597. 3 indexed citations
11.
Brend, Tim, et al.. (2012). The Her7 node modulates the network topology of the zebrafish segmentation clock via sequestration of the Hes6 hub. Development. 139(5). 940–947. 36 indexed citations
12.
Brend, Tim & Scott A. Holley. (2009). Zebrafish Whole Mount High-Resolution Double Fluorescent <em>In Situ</em> Hybridization. Journal of Visualized Experiments. 107 indexed citations
14.
Brend, Tim & Scott A. Holley. (2009). Zebrafish Whole Mount High-Resolution Double Fluorescent <em>In Situ</em> Hybridization. Journal of Visualized Experiments. 7 indexed citations
15.
Brend, Tim & Scott A. Holley. (2008). Balancing segmentation and laterality during vertebrate development. Seminars in Cell and Developmental Biology. 20(4). 472–478. 13 indexed citations
16.
Brend, Tim, Jonathan D. Gilthorpe, Dennis Summerbell, & Peter Rigby. (2003). Multiple levels of transcriptional and post-transcriptional regulation are required to define the domain of Hoxb4 expression. Development. 130(12). 2717–2728. 46 indexed citations
17.
Gilthorpe, Jonathan D., Marie Vandromme, Tim Brend, et al.. (2002). Spatially specific expression ofHoxb4is dependent on the ubiquitous transcription factor NFY. Development. 129(16). 3887–3899. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026